Medtronic has issued a safety
advisory, in consultation with the
Therapeutic Goods Administration
(TGA).
The advisory highlights the need
to confirm insulin dosage when
using certain Medtronic Paradigm
insulin pump models, due to the
risk of over-inflation.
Medtronic said this followed a
small number of reports about
users who had accidentally
programmed the pump to deliver
the maximum amount of insulin
when in ‘bolus’ mode.
This included one case which
resulted in severe hypoglycaemia,
the company said.
The TGA said it had received one
Australian report where this issue
led to a patient being hospitalised.
Consumers and health
professionals should have received
a letter from Medtronic with more
information.
To read more, CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 15 Apr 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Apr 14
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.